Literature DB >> 24453215

Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli.

Pascal Egloff1, Matthias Hillenbrand, Christoph Klenk, Alexander Batyuk, Philipp Heine, Stefanie Balada, Karola M Schlinkmann, Daniel J Scott, Marco Schütz, Andreas Plückthun.   

Abstract

Crystallography has advanced our understanding of G protein-coupled receptors, but low expression levels and instability in solution have limited structural insights to very few selected members of this large protein family. Using neurotensin receptor 1 (NTR1) as a proof of principle, we show that two directed evolution technologies that we recently developed have the potential to overcome these problems. We purified three neurotensin-bound NTR1 variants from Escherichia coli and determined their X-ray structures at up to 2.75 Å resolution using vapor diffusion crystallization experiments. A crystallized construct was pharmacologically characterized and exhibited ligand-dependent signaling, internalization, and wild-type-like agonist and antagonist affinities. Our structures are fully consistent with all biochemically defined ligand-contacting residues, and they represent an inactive NTR1 state at the cytosolic side. They exhibit significant differences to a previously determined NTR1 structure (Protein Data Bank ID code 4GRV) in the ligand-binding pocket and by the presence of the amphipathic helix 8. A comparison of helix 8 stability determinants between NTR1 and other crystallized G protein-coupled receptors suggests that the occupancy of the canonical position of the amphipathic helix is reduced to various extents in many receptors, and we have elucidated the sequence determinants for a stable helix 8. Our analysis also provides a structural rationale for the long-known effects of C-terminal palmitoylation reactions on G protein-coupled receptor signaling, receptor maturation, and desensitization.

Entities:  

Keywords:  detergents; membrane proteins; protein engineering; protein stability

Mesh:

Substances:

Year:  2014        PMID: 24453215      PMCID: PMC3926081          DOI: 10.1073/pnas.1317903111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists.

Authors:  Beili Wu; Ellen Y T Chien; Clifford D Mol; Gustavo Fenalti; Wei Liu; Vsevolod Katritch; Ruben Abagyan; Alexei Brooun; Peter Wells; F Christopher Bi; Damon J Hamel; Peter Kuhn; Tracy M Handel; Vadim Cherezov; Raymond C Stevens
Journal:  Science       Date:  2010-10-07       Impact factor: 47.728

Review 2.  G-protein-coupled receptors, cholesterol and palmitoylation: facts about fats.

Authors:  Bice Chini; Marco Parenti
Journal:  J Mol Endocrinol       Date:  2009-01-08       Impact factor: 5.098

3.  Directed evolution of a G protein-coupled receptor for expression, stability, and binding selectivity.

Authors:  Casim A Sarkar; Igor Dodevski; Manca Kenig; Stefan Dudli; Anja Mohr; Emmanuel Hermans; Andreas Plückthun
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

4.  Crystal structure of the ligand-free G-protein-coupled receptor opsin.

Authors:  Jung Hee Park; Patrick Scheerer; Klaus Peter Hofmann; Hui-Woog Choe; Oliver Peter Ernst
Journal:  Nature       Date:  2008-06-18       Impact factor: 49.962

5.  Crystal structure of metarhodopsin II.

Authors:  Hui-Woog Choe; Yong Ju Kim; Jung Hee Park; Takefumi Morizumi; Emil F Pai; Norbert Krauss; Klaus Peter Hofmann; Patrick Scheerer; Oliver P Ernst
Journal:  Nature       Date:  2011-03-09       Impact factor: 49.962

6.  Neurotensin receptor 1 determines the outcome of non-small cell lung cancer.

Authors:  Marco Alifano; Frédérique Souazé; Sandra Dupouy; Sophie Camilleri-Broët; Mohamad Younes; Sadi-Menad Ahmed-Zaïd; Takashi Takahashi; Alessandra Cancellieri; Stefania Damiani; Maurizio Boaron; Philippe Broët; Lance D Miller; Christian Gespach; Jean François Regnard; Patricia Forgez
Journal:  Clin Cancer Res       Date:  2010-09-01       Impact factor: 12.531

7.  Evolution of three human GPCRs for higher expression and stability.

Authors:  Igor Dodevski; Andreas Plückthun
Journal:  J Mol Biol       Date:  2011-03-03       Impact factor: 5.469

8.  The structural basis of agonist-induced activation in constitutively active rhodopsin.

Authors:  Jörg Standfuss; Patricia C Edwards; Aaron D'Antona; Maikel Fransen; Guifu Xie; Daniel D Oprian; Gebhard F X Schertler
Journal:  Nature       Date:  2011-03-09       Impact factor: 49.962

9.  Structure of a beta1-adrenergic G-protein-coupled receptor.

Authors:  Tony Warne; Maria J Serrano-Vega; Jillian G Baker; Rouslan Moukhametzianov; Patricia C Edwards; Richard Henderson; Andrew G W Leslie; Christopher G Tate; Gebhard F X Schertler
Journal:  Nature       Date:  2008-06-25       Impact factor: 49.962

Review 10.  Role of helix 8 in G protein-coupled receptors based on structure-function studies on the type 1 angiotensin receptor.

Authors:  John Huynh; Walter Glen Thomas; Marie-Isabel Aguilar; Leonard Keith Pattenden
Journal:  Mol Cell Endocrinol       Date:  2009-04-29       Impact factor: 4.102

View more
  78 in total

1.  G protein-coupled receptors: the evolution of structural insight.

Authors:  Samantha B Gacasan; Daniel L Baker; Abby L Parrill
Journal:  AIMS Biophys       Date:  2017-08-21

2.  Identification of destabilizing and stabilizing mutations of Ste2p, a G protein-coupled receptor in Saccharomyces cerevisiae.

Authors:  Jeffrey Zuber; Shairy Azmy Danial; Sara M Connelly; Fred Naider; Mark E Dumont
Journal:  Biochemistry       Date:  2015-02-24       Impact factor: 3.162

3.  Toward high-resolution computational design of the structure and function of helical membrane proteins.

Authors:  Patrick Barth; Alessandro Senes
Journal:  Nat Struct Mol Biol       Date:  2016-06-07       Impact factor: 15.369

Review 4.  Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs.

Authors:  Sang-Min Lee; Jason M Booe; Augen A Pioszak
Journal:  Eur J Pharmacol       Date:  2015-05-14       Impact factor: 4.432

Review 5.  Membrane proteins, detergents and crystals: what is the state of the art?

Authors:  Patrick J Loll
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-11-28       Impact factor: 1.056

Review 6.  Methodological advances: the unsung heroes of the GPCR structural revolution.

Authors:  Eshan Ghosh; Punita Kumari; Deepika Jaiman; Arun K Shukla
Journal:  Nat Rev Mol Cell Biol       Date:  2015-01-15       Impact factor: 94.444

7.  Prediction of Conformation Specific Thermostabilizing Mutations for Class A G Protein-Coupled Receptors.

Authors:  Suvamay Jana; Soumadwip Ghosh; Sanychen Muk; Benjamin Levy; Nagarajan Vaidehi
Journal:  J Chem Inf Model       Date:  2019-08-27       Impact factor: 4.956

Review 8.  New approaches towards the understanding of integral membrane proteins: A structural perspective on G protein-coupled receptors.

Authors:  Reinhard Grisshammer
Journal:  Protein Sci       Date:  2017-06-07       Impact factor: 6.725

9.  Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA.

Authors:  Juan Carlos Almagro; Gary L Gilliland; Felix Breden; Jamie K Scott; Devin Sok; Matthias Pauthner; Janice M Reichert; Gustavo Helguera; Raiees Andrabi; Robert Mabry; Mathieu Bléry; James E Voss; Juha Laurén; Lubna Abuqayyas; Stefan Barghorn; Eshel Ben-Jacob; James E Crowe; James S Huston; Stephen Albert Johnston; Eric Krauland; Fridtjof Lund-Johansen; Wayne A Marasco; Paul W H I Parren; Kai Y Xu
Journal:  MAbs       Date:  2014-03-03       Impact factor: 5.857

10.  Conformational Changes in Tyrosine 11 of Neurotensin Are Required to Activate the Neurotensin Receptor 1.

Authors:  Fabian Bumbak; Trayder Thomas; Billy J Noonan-Williams; Tasneem M Vaid; Fei Yan; Alice R Whitehead; Shoni Bruell; Martina Kocan; Xuan Tan; Margaret A Johnson; Ross A D Bathgate; David K Chalmers; Paul R Gooley; Daniel J Scott
Journal:  ACS Pharmacol Transl Sci       Date:  2020-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.